Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@david the data will show how it performs, the advantage Genedrive will have long term is the data from the highest throughout tests which effectively are the same test run on a different platform. In diagnostics it’s a huge benefit to have both lab based and point of care tests being one and the same. It’s a confidence thing. With molecular testing (I’ve been in it for 20 years) LAMP has always played second fiddle and never achieved the accuracy or sensitivity of PCR. That’s not to say it won’t here, just for me as a seasoned professional I don’t see why a crisis solves the issues it had previously. The reason why optigene are doing it is that it’s an easier system to develop. Will it work at 40C in india like Genedrive? Let’s see :)
At last some sober replies! I agree that the size of the market may be that there is room for many players and that GDR will most likely get to market before Optigene. However I am minded of the old saying that if you invent a better mousetrap people will beat a path to your door.
What I do object to is the 'echo chamber' mentality where any critical comments are shouted down. We need to be as objective and as truthful as possible because the only people to be deceived are ourselves.
It is still under trials and takes 4-6 weeks to complete the trials. Until then we don't know if Optigene test has 100% specificity and 100% sensitivity. Any false positives reporter then it goes into the bin.
GDR has CE mark already and 100% sensitivity and 98.2% specificity. DB mentioned that time has been taken to properly validate the accuracy of the product.
Moreover first commercial sales in UK is in June and will be distributed in India, Africa and US. While Optigene is being validated, GDR will be making commercial sales. With WHO approval, sky is the limit for GDR.
@david I take the view that the opportunity is such that a number of poc systems will be successful. My personal opinion with LAMP based tests such as the OptiGene test is that there are no clinical diagnostics success stories. Despite many attempts qPCR remains the front runner in terms of sensitivity and robustness to interfering substances. That’s not to Optigene haven’t cracked it, but I have my doubts as I did about Abbott when they launched their isothermal tests which long term posters will remember I questioned on sensitivity too. It was recently shown to be indeed an insensitive test... time will tell
The link given was dated 2 April and details Optigene's technology. The latest tweet on Optigene's account says this :
"OptiGene Limited Retweeted
Hampshire Hospitals
@HHFTnhs
·
May 22
We're so proud to be trialling a rapid test in our emergency departments & in the community. That we are able to do so is a testament to the hard work and ingenuity of our entire microbiology department."
And this from UK government on May 21:
https://www.gov.uk/government/news/trial-of-rapid-coronavirus-test-launched-in-hampshire
Far from the trials having failed they are due to complete in the first week in July.
I'm afraid the hysterical, uncritical tone of this bulletin board may cause some people to lose money.
HI Daivd
we discussed this company back in April when the story broke in the nationals
I believe technick could answer your questions but purely on a practical note we have heard nothing about it since and they have had over a month now.
if I remember correctly they were not accurate enough but others here are better placed to educate you in the science.
I doubt many here will take your post seriously due to the tone of it though.
Optigene link http://www.optigene.co.uk/wp-content/uploads/2020/04/OptiGene-Press-Release.pdf
St Tropez. Please provide a reference to a report that the Optigene trials have been discontinued. There are people on here who might believe you.
It spotted the reverse sinep!
Hanprick Handick Hanwilly Han***** ?
try again - Ckoc
*******
This is the company that Matt Han**** alluded to. It has a twenty minute test that doesn't require a lab. You don't have to send the sample away and the test subject can wait for the result. Why are you not discussing this? If it is approved it will blow GDR away.
I searched hard and long today for discussion of the competition this company faces and found none. The whole world and his dog is trying to crack this problem and all I saw was a lot of excited speculation about the share price.
By the way, before I go - I've got some unique tulip bulbs which I could let you have for a very reasonable price...